Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9wM1p0UDA1VUFxalJnTnd2WkpQVDB6MHhsRmRNejY2Y09mckhRTlc5ai1LQUZ1aGk5NUZhTVVacVpPNi12cXN0MU1JcmtGdXpHX2VxZVhSV3BlQkZwNnNPZWVNall2aWxVSldOTXpxb2dzSTAzSkHSAXtBVV95cUxPTmVBSlpvM3VpUzZ2bDRPNlVSMWI3RWJLeFFFRk9TdXRuUFNjZDUyQU0yeDVqcXdSVGZKU3ZxQ1ZzNTJHdjNrOVM2dVliSG90eHp0V3hQVGZ2bWNJOV8wZHZKdExYaWZrMklHYXllQTZfN3dMUTExY3RRNHc?oc=5" target="_blank">Over 1.1M people using GLP-1 drugs without FDA-approved reason</a>&nbsp;&nbsp;<font color="#6f6f6f">NewsNation</font>
"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
OpenAI engineer arrested in bugging of executive conference room
The Myth of St. Francis
Bayern’s Michael Olise sent off for 2 yellow cards within seconds in Champions League
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxONnRKSW1oTWY4cjJVZHJ3RE9sUzNDRkR6djVvcy10dWdqWjFMNklEMy1rVVVaNFdQTHltaWJFcnFFYi1SbUpCNnJLX2liZ0dNM2RESGZ1a095VWwtVlc1Q2FmSmxVblR2dnZxRFlYVDdmMGtPcUd6YXV1WC1kSnVaNEhJYmd2UjZrdnNYZ1NRMA?oc=5" target="_blank">GLP-1 Medications for Weight Loss: How to Get Started</a>&nbsp;&nbsp;<font color="#6f6f6f">Yale Medicine</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOdlRRdGU3a2N6dEEzQW9LQ3Y3eDVPZ3lxOWM2S0ZPdjdLQ1FkSk9Oc0g2MU16eTZQOXdXNXJxUlNqUUxFbXc3a1VPTUpSbk9CZE9aWmNPYjFqeGRFTXpQNlZxS2szbFZHNk9tc3JRNlVLd1BTZTlNRkZ2RFh6WUgwbUJoeVJCTzg0M2pldzd0MHo3R1o1Y1lMVUpwWmdSZ0trdFlHUUxodURaSFluemh3?oc=5" target="_blank">GLP-1 Weight-Loss Drug Demonstration Begins July 2026</a>&nbsp;&nbsp;<font color="#6f6f6f">Medicare Rights Center</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQdHF6ZGFScGpPZE54bGNieFpsRG9JQVgzQjA2MzlGRldldHRpdGFNSWtpTnJOSVlPSGprYTdXT09YczFtNXA1Vi1CemRUeHIyZEszTGdDcVNMYnFRMTJKdTVrejdQSlBZUVdJeVcyQ0NTamNEc1VNWl9feFdjOFNpODQ4Ykl1MkRUMUhV?oc=5" target="_blank">new fda approved weight loss drug 2024</a>&nbsp;&nbsp;<font color="#6f6f6f">polskieradio.pl</font>
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQTnZqZWZ4TWk3VVBRcDJKTEZRdmJRb1VRQWpibHV4VFBkeC1fNXZUWV9PaThEcFFNcDQxSnJlMUlNNVpRb1VpVkhzdHJuZlpiX3VaRjl1c1NPN2pMMUNmNGFYbFgyTF9leFk3YXQtSkV4c3pKVG9zak1MNENOSThHcWRUT2w?oc=5" target="_blank">Are GLP-1s everything we hoped for?</a>&nbsp;&nbsp;<font color="#6f6f6f">Mayo Clinic Press</font>
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxOdU1KLXd1aWdFdlNoeTBua3VZMUloVFYyZ0E0Y0o4a1drX19MMDVQdlBuYTU2X0pHNDZzUDVFV1FiS0ZLSHBPbG1HbEMzbllTS2RmemFERGpmdkhhX09SUThWSDVGaGdtbzZZTlZHMElFcUFPZ0ZJb1FhWjA1blVPeFVB?oc=5" target="_blank">Another GLP-1 weight loss pill gets FDA approval, and it has fewer restrictions on how it’s used</a>&nbsp;&nbsp;<font color="#6f6f6f">CNN</font>
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNUEdULTd1TEZFSTFsVXB5TVdWXzJiZkZjX3lTQTJxZFdzUEt3dms3LVFlSFN3RmxreU1RMkZBSGZXd3B4S00wSVR5U0hnVUpyUTNuYUg0OXBLYklSWlF3OW9URHNSYS05S3FKU3ZUamwzR0VHM2ZySm5iYmtNX3dmYlNaNno3T0xFZ0xDNU9HLTJPemFpNDdfdk5vb2k1dHY4VEtSck52WkZwdUnSAbABQVVfeXFMTjRwcV92N1Y4SXB5MWlLaXhuOVpFZ2Z2dW0yVDVDSlloOFp5RXR3WllKR1ZncER0N1ZBV1BackMyMlJ1c2d4ZFZDa1dyTDI2YXNfWGR1NEFJZ21udVdqcXZiRW81WUNrcktKcC1mS1l4X0ZUVUZTMmdBTGZEclRFbGZzX3pzeVBVWFp4MzA3TjRnN2JMczRKMFIwX1MtQkZSSGRQay1pX3F2M09uNFNfam8?oc=5" target="_blank">U.S. signals crackdown on compounded weight-loss drugs; Hims shares tumble</a>&nbsp;&nbsp;<font color="#6f6f6f">CNBC</font>
<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQUDRueXp3cEoxbHhoMk12R1V5ak1ZRmxDeFYxcVI1cnZGbnJMUHkyTm9iRTNMYWxMdjY0bFNQZ2xzT2pSTzIzSGdhdElfR3MtbjFKdjlGWVZBckhOVHkwMmhBb202b19kVTFHb1BMNzJWb2E4WXM1QmFKTC1Nd2d4QmJUMGZOVXc?oc=5" target="_blank">FDA approves new uses for GLP-1 diabetes drug</a>&nbsp;&nbsp;<font color="#6f6f6f">WBAY</font>
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxNTWR4X3dkUzZVSGJzVlZNbDZ2V1dCcjNCRHJQZnNrQ19CeVVPbWhkLUFZWkJGeFFBNEtRSERuNF9OVUVreWRqXzM3bzVGNWFlMndZaEtoR1VZeVp3cXdyaFFDbkgtNkMxU3czc2RXTnhhS1NZLThEZ3c1U1JPRFE4LXJmNXFsc2ZZdlFMdk56ajRxTW9rZ3liNlp2MFVMWExfMHRveGdIQUt4UU9KbWpUWUZPMlNDY2ItLWhQZ2daVkp5WTVvRlk1d1lySXRGNTNj?oc=5" target="_blank">Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey</a>&nbsp;&nbsp;<font color="#6f6f6f">Walgreens Corporate Site</font>
<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE1VSllSdmtqM2VvTW1wTHExNUxaTlpycTJ3U0FwMUhxdjRBdGtkaDB0SjJwQmlsMllIZWVQMWlTV1NxOFZkaElpRXhXdVdXODVSLTV0LTJ6VFdkRXc?oc=5" target="_blank">Eli Lilly’s oral GLP-1 drug sees rapid uptake after FDA approval</a>&nbsp;&nbsp;<font color="#6f6f6f">Fox Business</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQSlBVSzN4eHhaTC1iRnV4NDZDUXpvQ1Fkb1dyaHNEcHcyRWJtSEI3NjVCTmVfUHBLcF93c1RNZXl4dU1CZDh1RGNDNS1JZ0VvWGU5NmUzS09VSXZHdHgwRFdoUFZZTmpVMWV4YWJ4YzZJN2lGVWpSZnVnRURFd2dBY1pweC1Zek5keTNpbm9aTXNTa084WENZ?oc=5" target="_blank">US FDA approves Lilly’s Mounjaro to reduce cardiovascular risk</a>&nbsp;&nbsp;<font color="#6f6f6f">WTVB</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNcGtrR0tJV3ZZYnNJUlEta0hMblpyQWF5VWluRXBWbzBMUWdlN3BSUVVwX2FSQXNHS182b2NSZ19YcW9JSEwzNFVuQTVpdlRUcUxIV2tmenE0SzF5X013WUUzdzh2T0o3T2FpZkVERFAzUzRKVHZfN3d5ZEtfSWpqcGxPRi03U0lFQnRQMFFubDdDdw?oc=5" target="_blank">Does Medicare Cover Weight-Loss Medications Like Zepbound or Wegovy?</a>&nbsp;&nbsp;<font color="#6f6f6f">GoodRx</font>
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE1Pelp6SDJPMGFQUjRSenhhSHJUdWF6cXpfV25lUldNNkRBOE1xaFBDQjhmYVRld2pkSzZza0FMQkNqdlJiT09fQ1N5Ym53X20xTnVSX1RVbm1lNHVITTNhUEprb2FmR3RYazdzXzNoX2haSXRuaTFQNnlaWmVXOGs?oc=5" target="_blank">4 FDA-Approved Weight Loss Medications, Recommended By Experts</a>&nbsp;&nbsp;<font color="#6f6f6f">Forbes</font>
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPZHlqcnJiZFNaMXZuSXlZWU1tWER3cUR6YnJPR01XR1ZIUGIzNG1zNUpPaTAwZmQ1SXhMUFQtTEc3YUQ5QTctVHVaZkptY0c3VVc3a3ZBWXRwb0NnQnJCZGQ0ZFZFNDZiVEpLQUxMeGdyTWlVYmhja2VuTTRTbzByTlMtempvVDdBZmFkeW00bjVWUXhBNlJkbHpzS1BYS1B5ZEhzUQ?oc=5" target="_blank">Ozempic, Wegovy, Mounjaro, Zepbound: Differences — and What the VA and Tricare Actually Cover</a>&nbsp;&nbsp;<font color="#6f6f6f">Military.com</font>
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE00NDU3ZlYyblFrMTV1UkNvMGladnVpcTl5bnFObVNLa2NvWmxNUzNHbkNGcnNwQnBSVUo5bDlYSGV4S01YYW1EMldXaDdOaTQ5UHQ3aFp2alkzZk1aNERkTW0zaXR5bTdPcXNaMjNzLXNtcGx2S2c?oc=5" target="_blank">GLP-1 Interactions: Risks, Effects, and Recommendations</a>&nbsp;&nbsp;<font color="#6f6f6f">Endocrinology Advisor</font>
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNcmx5SnU4R0tGMWI1MGhJbjlVMUNtZTdTZWttV1AzMDE4QXM2dDlrNDlXZjFEc0x5aVBxWkN2MWlvOUxwR1pPeFMxMXNjdVBWMzJUZUxtVDNGVncwZTZtUWZsV0lzZGY1NDBRMEl3RFRMTnJIWThWNEk5akNTZ0xUWGlGU1NSejJUbnlDbHp3el9hRUxSV2xtLU5LVjJIREViVnl1WlN0Q1M?oc=5" target="_blank">fda concerns unapproved glp-1 drugs used for weight loss</a>&nbsp;&nbsp;<font color="#6f6f6f">www.polskieradio.pl</font>
<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE5qbUkwNlppaGllTk9uQ1V0WkNveTRhVlVBRDNJanJySkRUTE1iUXNRbHhibzMzMW10alVmWDBQN3BDRHJib0ZSalNUdFAzeENicXBmQVNLcm5RS1VWOWJJQVRjdWI2R19GZ0UtVWsyblNZUQ?oc=5" target="_blank">Ro Body: Weight Loss Medication Review (2026)</a>&nbsp;&nbsp;<font color="#6f6f6f">Forbes</font>
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE5KMGF3NFp1bE9uV09fMndxUmpzU1VOMnhQdDNYOF9ld1FpTWRpM0dvTG9HWmFSWXdwWThmZVREdkdnNWJyS0tNQWc5ZGl4VHA0V0NWNXAwNmhDLWdlT2hBLXhhazVLYW42X2ZNeUNGdUg?oc=5" target="_blank">6 FDA-Approved Alternatives To Ozempic For Weight Loss</a>&nbsp;&nbsp;<font color="#6f6f6f">Forbes</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQdVY5dVdfS3ZaT0szWnE0TEozMThOZnRpdUEyOXRLYTU0Vm5MMG9CNkVsTjY0eGVaWDY2dDB3S0xhdzlBdW9aRTdWVV82QU9tZEVCaE1TOXh5UDJnYjk1ZW1Xd2VLMkwzdDVrbWotc2VETlJyb3lfbjNnLUJRWmtWcURGNElfWTl2bkxydzRRamxtMENHNlNJQnR6RnFFRmEtUDQ5cHFR?oc=5" target="_blank">Life-threatening GLP-1 overdoses are on the rise — what’s behind the scary increase</a>&nbsp;&nbsp;<font color="#6f6f6f">New York Post</font>
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOS0RfWng4d1VmY0lvSExqMlRnbmgzNWN5YkxJWXZfMXFJaDZORVQzeU5uVFR3OW5qRzRqQjBLS3VRS0I0eUpxVHFwMlZpMW42Umw0SVZuMWhNR3lHTTFmQXVYdDJxaDJvUW9TLTIwbExfdDEzek1ZMldrNThtSGR3cHlwcGNtLTdlV2dYNW1sb2Q?oc=5" target="_blank">GLP-1s Hold Promise as Treatment for Alcohol Use Disorder</a>&nbsp;&nbsp;<font color="#6f6f6f">Gastroenterology Advisor</font>
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTFBPRlFBZTFUNVpvcl9odnEzel9PZVZHRFVWYk42MjE0WVNFYklycUEzaGthMkJ5NXZzSWNfUE1qX3htVWhKeXdpYUFIMlRBaEFMcEdIbVJZeGVGU2didHJDX2dKZmNoQVlvcE1nTURGbTlod3B1Yy04dHByTnliZw?oc=5" target="_blank">The Weight-Loss Drug Wegovy Now Comes in a Pill</a>&nbsp;&nbsp;<font color="#6f6f6f">Time Magazine</font>
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNUGItcVRJdWFFREMteVg4V2QyU0FSejZCTGVCQWE1UElRVnVyNG9uY25QV21GellVVzAyQ0VFVG85THJoYk9iVmdIQnZOazlKQ0NablIwZ25TZU05aGpJcnFtX081M2tvXzJobkJvRUpGM0xESUVjMmJmc1d4aGd4REZjUi1VbU1PSm00OTFkYWFIbC1pUVFGZHZKaldEQXc?oc=5" target="_blank">Monster of 2025: GLP-1 Ads</a>&nbsp;&nbsp;<font color="#6f6f6f">Mother Jones</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNN3l0LVMtYU44bU1TWHlJNWFkYmg1Y0s0YUxaWWtUZDF1dkFlNUNEVUR1Rlc2S1U2NF9GdDNWcURlc3NZZWZTa2ZONWZua1d4ekd2TXRTNXRlOFJlOHRPOHBFZnhZcmJ5c3otNlFCUVNmVlRNb3RrV1pfRDdXU1ZOWnlCbXAtUS1xRGF5SWVYck9GdHgyLW56RmtiVTV3UmV0?oc=5" target="_blank">Compounded GLP-1s: Why doctors worry and the FDA is cracking down</a>&nbsp;&nbsp;<font color="#6f6f6f">Stanford Medicine</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNOWlHd2hYeVFyMzJRTnVINUhlY2ZqZnhacHFDRktYbzdHVXE3REhiWl9ZWl9KZGVnM2N1OUNlX21OSGlldDRxMDd6bEc3TzRROElEOFo3YjZoZjdvY0xTRWxaS29lN1BfMU1pMEE1ZnZUYUdOLVJFUXl2dnIwY0xUNFdRdlphVkVZLVV6M3prMGpiUnNwMzF3?oc=5" target="_blank">Allurion Receives U.S. FDA Approval</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Wire</font>
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE1HR2pJQXJsR0JMdGpBX2JINnZaLTk0S3JUd1dsWDVWTVp1WlpDSUs5ZFlzNC03ZTQySzJ4cTZOelRQM2JqUHJiUkxac3llMUE0Tlo0Mlk2ZmZqeXRVSEJ4aUg0TVlYRUFmT2pNVUhsVFQ3MURPelB0amtNNnZBUQ?oc=5" target="_blank">Regulatory tracker: FDA starts review of Sandoz's generic tirzepatide</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOVWlOSi11SGlYQlNoTld3QjBfWGJHRVJudWM2TXAyanJ1YUt1R1NUQnFxS0M4NDVUUXE3cmMyZ0diNU44am9sZXZGcDZiQmZHV2pudmp0Q0ozNS1RYzdPYXpsYlNxX1FUN1NCY0NQSTdFQVJCNzRFUUhrbjRGa3FFNkVzTWl5MHdBVzQ3c2dudHFXa09wUHVV?oc=5" target="_blank">7 things to know about Medicare’s new GLP-1 coverage</a>&nbsp;&nbsp;<font color="#6f6f6f">Michigan Medicine</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQa0V0LVhlcGF6MENqMDRzdHBla1FoX29GZ3FSWjVLWlZVSUdfRnpxVmVfaDFDUjNrcDF3YnQ3a2pfS1hienRIVGlYd2FOYWVBRUdMUlROWVhkZUpIWV9rRENKSnhsVllscGxjZzQ2WGRwY2V1ZFlYRUp2TWlZbGNIcUFETElFcHRGNXZfLXJjS0gzNWJmeGpBcFkyM05TQQ?oc=5" target="_blank">Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns</a>&nbsp;&nbsp;<font color="#6f6f6f">The American Journal of Managed Care</font>
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1fWkQyTlZhNVNiVExpQV8zRlRqOVotVDd2cEw2R01pQW81VnByX3ZXNG9BOEhJXzcwM0didWRoVm8tLWxXTTExdU04RERJR0hHZ1ZHNDRBMHBNV3QtSW5DX0hRY191ZnZJQzNpaA?oc=5" target="_blank">The Emerging Role of GLP-1s in Type 1 Diabetes</a>&nbsp;&nbsp;<font color="#6f6f6f">Beyond Type 1</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOOHgwQ2piZzVnOENGQnl0OU9od1V4NVJ4c2xDRTROOTVyTEk0M2tYQ3VQNWlvVFU0bE9JM0s4NmtBZEotcWVWWF9JaG4xYllOY0kwbXFoODl4UmV3OVRlZFhIMFJNc2RBQ2pmM0tudHk4Ql92OUJlSjgzS3dIOVFadTJxcUJLX0tydy1PQUZtcF9LZ1ZZbTZv?oc=5" target="_blank">Five things to know about GLP-1s and addiction</a>&nbsp;&nbsp;<font color="#6f6f6f">Stanford Medicine</font>
<a href="https://news.google.com/rss/articles/CBMiqgJBVV95cUxPV1RBVENTcmsxM3NnSUxKM01Xb0Q2OFRoeDZhV3JlOG9wUnN5ZmNGbUxDRlZscGZ6NmdNRjJwZzVueEg4U3VoQVVsZzJQRVdBOFdRaG5iVk54OENSZGM3aDRDT2Ewd3lxTk8xZkQtQ01KTFdHTFk4UkY5bXlRUGlIVmwyejN3MENzbVZvUjJ3VlR1bWJ6ZnloX0ljbzhyTUhKaUROWk93dGNEc3JXMmZNdEs3bjdUaFdpbThpMUN6Zk5PZ1hWSUF1YThNSnNGUzB1SnRoczRxY0lhSV96czRqSjZmb1N2Yi1kRnlUa0tlbVRUZk1Scjc2VTZ4R2RWTWRwSjRWYkVCNnI1YUlNMlRpM3l4OHBjSTUwcHZvRFd6NXJqQmp0c0RCTmFn?oc=5" target="_blank">FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>